Novartis Transderm Scop Superiority Claim Disputed By Pharmacia In Petition
Executive Summary
Pharmacia is requesting that FDA modify the physician package insert for Novartis' Transderm Scop motion sickness patch to remove a statement claiming superiority to OTC oral dimenhydrinate.